Who owns Nalgesin?
Nalgesin is owned by Krka (Slovenia, LJSE: KRKG).[1]
This ownership is reported in official statements but has not yet been matched to a regulatory filing.
Evidence: Krka 2025 Annual Report, Krka, d. d., Novo mesto, 23 March 2026. Last checked .
Key facts
- Current owner
- Krka, tovarna zdravil, d. d., Novo mesto reported
- Owner HQ
- 🇸🇮 Slovenia, Novo mesto
- Origin
- 🇸🇮 Slovenia
- Category
- Consumer health › Over-the-counter medicine › Pain relief
- Parent ticker
- LJSE: KRKG WSE: KRK
- Last verified
- · 1 sources
About Nalgesin
Nalgesin is Krka's naproxen brand and its second-largest non-prescription product. The company says naproxen has gained ground in Europe for its fast onset and long-lasting effect, and that Nalgesin was in 2025 the leading single-ingredient naproxen medicine and among the ten leading non-steroidal anti-inflammatory drugs in Europe. It is sold over the counter as Nalgesin S and on prescription as Nalgesin Forte, and the same naproxen is marketed elsewhere as Analgesin, Ilgesin, Naldorex and Nalgedol.
Ownership timeline of Nalgesin
Where Nalgesin sits in Krka
Controlling ownership as of . Brands grouped under the entity that owns them; large groups are collapsed.
Open the full Krka ownership tree →
See the full Krka brand portfolio (18) →
Other brands owned by Krka
Krka controls 18 brands on Brandtree, 8 of them in consumer health.
Also in consumer health
Other brands in pain relief, and who owns them
The 37 brands in pain relief on Brandtree belong to 21 owners. The largest is Haleon, with 3; Krka has 2.
| Brand | Owner | Owner based in |
|---|---|---|
| Advil | Haleon | 🇬🇧 United Kingdom |
| Air Salonpas | Hisamitsu Pharmaceutical | 🇯🇵 Japan |
| Motrin | Kenvue | 🇺🇸 United States |
| Dafalgan | Taisho Pharmaceutical | 🇯🇵 Japan |
| Nicotex | Cipla | 🇮🇳 India |
| Mentho Plus | Emami | 🇮🇳 India |
| Bufferin (United States) | Genomma Lab | 🇲🇽 Mexico |
| Doril | Hypera | 🇧🇷 Brazil |
About the owner: Krka
Krka is a publicly listed company headquartered in Novo mesto, Slovenia, founded in 1954. Brandtree records 18 brands under its control, and it is listed as LJSE: KRKG and WSE: KRK.
Krka is a Slovenian generic pharmaceutical maker established in Novo mesto in 1954, listed in Ljubljana since 1997 and dual-listed in Warsaw since 2012. Group revenue was €2,041.0 million in 2025 and net profit €403.7 million. Prescription medicines are the bulk of it, but Krka also sells non-prescription products and animal health products, and its Slovenian subsidiary Terme Krka runs four health resorts. At home it is the largest supplier of medicines by value and says one in every five medicines sold in Slovenia is its own.
🇸🇮 Nalgesin and other Slovenian brands
Brandtree records a controlling owner for 31 brands that began in Slovenia. 10 of them (32%) are now controlled by a company headquartered in another country; Nalgesin is not one of them.
Frequently asked questions
Who is the parent company of Nalgesin?
The parent company of Nalgesin is Krka, a publicly listed company headquartered in Slovenia.
Is Nalgesin Slovenian?
Yes. Nalgesin originated in Slovenia and its owner, Krka, is also headquartered in Slovenia.
Is Nalgesin still owned by Krka?
Yes. As of 16 September 2026, Nalgesin is still owned by Krka. The ownership record was last checked against primary sources on that date.
Sources (1) & corrections
Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.
- [1] Krka 2025 Annual Report — Krka, d. d., Novo mesto, Annual report, published 23 March 2026; retrieved 16 September 2026.
Report a correction Opens a pre-filled GitHub issue. See our corrections policy.